Navigation Links
More than half of Texas physicians do not always recommend HPV vaccine to girls
Date:8/5/2009

PHILADELPHIA - The Advisory Committee on Immunization Practices recommends the human papillomavirus vaccination for all 11- and 12-year-old girls, but results of a recent survey showed that more than half of Texas physicians do not follow these recommendations.

The survey was published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

"Two years after the FDA approved the vaccine, the study suggests that additional efforts are needed to encourage physicians to follow these national recommendations," said Jessica Kahn, M.D., M.P.H., associate professor of pediatrics at Cincinnati Children's Hospital Medical Center.

The quadrivalent human papillomavirus (HPV) vaccine has been mired in controversy since it was approved in 2006. Texas placed itself at the center of that controversy early on with a mandate for universal vaccination from the governor's office, followed by a swift rebuke of that mandate from the legislature.

Kahn said she was approached by the Texas Medical Association to assist them in conducting this survey as part of their efforts to assess educational needs related to HPV vaccination among Texas physicians. Kahn and colleagues surveyed 1,122 physicians.

Of the respondents, 48.5 percent said they always recommend the HPV vaccine to girls, 68.4 percent said they were likely to recommend the vaccine to boys and 41.7 percent agreed with mandated vaccination.

When the researchers assessed the predictors of vaccine recommendation, they found that those in an academic vs. non-academic practice were more than twice as likely to recommend the vaccine. Those who considered professional organizations or professional conferences an important source of information were almost twice as likely to recommend the vaccine than those who did not consider these sources valuable.

"Most physicians are aware of the vaccine and what it prevents, but they may lack knowledge about issues of safety and how to address parental concerns. That may be making them reluctant to deliver the vaccine," said Kahn.

Although the study population was limited to Texas, Kahn said she believes that the views expressed by these physicians could be representative of physicians across the country. Nationally, vaccine rates for 11- to 12-year-old girls are between 6 percent and 25 percent.

"Physicians train all across the country using more or less the same curriculum, so as a group they tend to be fairly homogenous in their beliefs," said Kahn.

Sally Vernon, Ph.D., director of the Division of Health Promotion and Behavioral Sciences in the University of Texas School of Public Health, said this study points to the need to further educate physicians about the HPV vaccine.

"Physicians are the gatekeepers for this vaccine and the studies have shown that one of the most important predictors of health behavior is what your physician recommends," said Vernon, who is also an editorial board member of Cancer Epidemiology, Biomarkers & Prevention.


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. River delta areas can provide clue to environmental changes, Texas A&M prof says
2. River delta areas can provide clue to environmental changes, Texas A&M prof says
3. University of Texas at Austin engineer elected to American Academy of Arts and Sciences
4. Two innovative University of Texas at Austin biologists become HHMI Early Career Scientists
5. Texas Board of Education vote on the way evolution is taught could set national trend
6. Texas-sized tract of single-celled clones
7. Texas Obesity Research Center at UH assembles researchers to discuss obesity
8. Texas researchers provide emissions data for livestock industry
9. Famous fossil Lucy scanned at the University of Texas at Austin
10. Texas Medical Center researchers win collaborative grants
11. UT Southwestern scientist honored among best in Texas research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced ... comes after the company changed focus to making analytical tools for biopharmaceutical quality ... new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David ...
(Date:4/19/2017)... New York, NY (PRWEB) , ... April 19, ... ... working to combat Clostridium difficile (C. diff) infections through education and advocacy. ... lost her life to a C. diff infection, the foundation has become the ...
(Date:4/19/2017)... April 19, 2017  As a Bronze ... Heroin Summit ,  Proove® Biosciences, Inc. announces ... environmental, and lifestyle factors to accurately predict prescription ... of Southern California (USC), the Interventional Pain Institute ... publish results showing that Proove Opioid Risk® accurately ...
(Date:4/19/2017)... 2017   Thermo Fisher Scientific Inc . ... MOnitoring SEpsis (MOSES) Study have been published in ... Care Medicine . Researchers from the study, titled ... Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) ... (procalcitonin) assay to assess risk for 28 day ...
Breaking Biology Technology: